Liver clinic program aims to tackle alcohol use disorder

NCT ID NCT07525258

Recruiting now Knowledge-focused Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new program designed to help liver doctors provide treatment for alcohol use disorder. The program includes education for doctors and patients, decision support tools, and feedback on performance. Researchers want to see if this approach is practical and acceptable to clinicians. The study involves 30 healthcare providers from Yale liver clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Implementation Intervention (education, decision support, feedback)
What this could lead to: If successful, this could lead to a practical way for liver clinics to routinely offer alcohol use disorder treatment, potentially reducing liver complications.
What could go wrong: This is a small, early feasibility study with only 30 participants, so results may not apply broadly. The program may not be adopted by clinicians or may not improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcohol abuse alcoholic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL USE DISORDER ALCOHOL-ASSOCIATED LIVER DISEASE

Contacts and locations

Locations

Yale School of Medicine/Yale-New Haven Health
RECRUITING

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.